- Home
- PCYO vs DCTH Comparison
PCYO vs DCTH Comparison
Compare PCYO & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCYO
- DCTH
- Stock Information
- Founded
- PCYO 1976
- DCTH 1988
- Country
- PCYO United States
- DCTH United States
- Employees
- PCYO N/A
- DCTH N/A
- Industry
- PCYO Water Supply
- DCTH Medical/Dental Instruments
- Sector
- PCYO Utilities
- DCTH Health Care
- Exchange
- PCYO Nasdaq
- DCTH Nasdaq
- Market Cap
- PCYO 307.4M
- DCTH 305.2M
- IPO Year
- PCYO N/A
- DCTH N/A
- Fundamental
- Price
- PCYO $12.76
- DCTH $9.39
- Analyst Decision
- PCYO
- DCTH Strong Buy
- Analyst Count
- PCYO 0
- DCTH 4
- Target Price
- PCYO N/A
- DCTH $21.50
- AVG Volume (30 Days)
- PCYO 43.3K
- DCTH 445.4K
- Earning Date
- PCYO 11-13-2024
- DCTH 11-08-2024
- Dividend Yield
- PCYO N/A
- DCTH N/A
- EPS Growth
- PCYO 152.63
- DCTH N/A
- EPS
- PCYO 0.48
- DCTH N/A
- Revenue
- PCYO $28,747,000.00
- DCTH $22,644,000.00
- Revenue This Year
- PCYO N/A
- DCTH $1,562.76
- Revenue Next Year
- PCYO N/A
- DCTH $117.72
- P/E Ratio
- PCYO $26.58
- DCTH N/A
- Revenue Growth
- PCYO 97.09
- DCTH 945.91
- 52 Week Low
- PCYO $8.94
- DCTH $2.38
- 52 Week High
- PCYO $13.40
- DCTH $12.88
- Technical
- Relative Strength Index (RSI)
- PCYO 69.09
- DCTH 40.91
- Support Level
- PCYO $11.50
- DCTH $10.11
- Resistance Level
- PCYO $13.40
- DCTH $12.88
- Average True Range (ATR)
- PCYO 0.51
- DCTH 0.66
- MACD
- PCYO 0.15
- DCTH -0.23
- Stochastic Oscillator
- PCYO 78.31
- DCTH 12.75
About PCYO Pure Cycle Corporation
Pure Cycle Corp is a diversified land and water resource development company. It designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in two business segments namely Water and wastewater resource development and Land development. It generates maximum revenue from the Land development segment. The company's services include water production, storage, treatment, bulk transmission to retail distribution systems, wastewater collection and treatment, irrigation water treatment and transmission, construction management, billing, and collection. The land resource development segment includes all the activities necessary to develop and sell finished lots.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.